Who invested in Algenesis

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Chemicals & Materials

Funding summaryUpdated 26 Oct 2026

$3.0Mraised across 1 round since 2024, from 1 source

Latest round: Venture, $3.0MOct 2024
Investors: 2

See who backed them

The rounds

Oct 2024
Venture$3.0M
- National Science Foundation
- US Department of Energy
Source recordedSEC filing: $3.0M sold, first sale Oct 2024

Founders and team

From Algenesis's own website: 1 founder, 14 on the team.

Dr. Stephen MayfieldFounder

Nick SandlandChief Business Officer
Pete MorganChief Financial Officer
Ryan SimkovskyChief Technology Officer
Ann KingOperations and Marketing Associate
Chris MayfieldDirector of Operations
Dan DearenVice Chair
Dan RosenExecutive Chair
Gordy ScofieldSenior Applications Development Engineer
Katherine O'SheaResearch Associate II
Marissa TessmanSustainability & Compliance Manager
Matthew HalloranSenior Scientist- Chemistry
Sandra WattsDirector of Marketing
Veronica BreckenridgeBoard Member
Wolfgang HafenmayerBoard Member

AdvisersPaul Saunders

Everyone who backed them

National Science FoundationGovernment1round

US Department of EnergyGovernment1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Algenesis as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.